María Ángeles Gálvez Moreno

An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism

István Takács, Emese Mezősi, Alfonso Soto et al. · The Journal of Clinical Endocrinology & Metabolism · 2024 · 32 citations

Medicine, Endocrinology, Pharmacotherapy +16

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Teresa Morán, Jia Wei, Manuel Cobo et al. · Annals of Oncology · 2014 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +17

Standard Hypercaloric, Hyperproteic vs. Leucine-Enriched Oral Supplements in Patients with Cancer-Induced Sarcopenia, a Randomized Clinical Trial

Aura D. Herrera‐Martínez, Soraya León Idougourram, Concepción Muñoz Jiménez et al. · Nutrients · 2023 · 23 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure—A Randomized Clinical Trial

Aura D. Herrera‐Martínez, Concepción Muñoz Jiménez, José López Aguilera et al. · Nutrients · 2023 · 23 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor Cells

Aura D. Herrera‐Martínez, Richard A. Feelders, Wouter W. de Herder et al. · Hormones and Cancer · 2019 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17